0GnGS37REIA https://histock.tw/talk/live.aspx?name=gtalk&id=1148 20220810 阿布波

台股 » 個股 » 華上 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

華上

(6289)
  • 股價
    2.71
  • 漲跌
    ▲0.14
  • 漲幅
    +5.45%
  • 成交量
    100
  • 產業
    上市 光電類股▲0.40%
  • 27人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
華上 (6289)籌碼相關-元大-大灣 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-大灣 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2022/08/02102.7000.002.70105119.31%
2022/08/0182.7900.002.7085115.48%
2022/07/2872.6000.002.6674914.12%
2022/07/18152.2500.002.29155228.64%
2022/06/30212.7100.002.72215240.15%
2022/06/29102.7200.002.72105119.27%
2022/06/28282.7300.002.72285253.49%
2022/06/27302.7800.002.78305157.75%
2022/06/24322.6500.002.65325162.34%
2022/06/0800.000.13.303.02-0.160-0.08%
2022/03/1103.1400.003.3002180.00%
2022/01/1000.00153.953.85-15147-10.14%
2022/01/07153.6900.003.69159915.14%
2021/04/2200.0023.653.65-2102-1.96%
2021/03/2222.9500.003.002822.42%
2021/03/05103.0200.003.02108411.84%
2021/03/03132.9000.002.89138615.09%
2021/02/2500.0023.103.10-286-2.30%
2021/02/2423.0000.003.002862.30%
2021/02/19103.0500.003.05108811.34%
2021/02/02652.8900.002.89659170.84%
2021/01/068.13.5000.003.708.11176.85%
2021/01/05543.3600.003.375411746.15%
2020/12/23143.6800.003.58141628.60%
2020/12/21763.5700.003.577618540.94%
2020/12/03203.8000.003.60203385.91%
2020/10/21144.0700.004.07143374.15%
2020/10/05164.84104.874.8063371.78%
2020/09/30104.4100.005.14103313.02%
2020/09/18105.36135.365.36-3228-1.31%
2020/09/10103.7100.003.71101347.41%
2020/09/0933.3800.003.3831242.40%
2020/07/2300.0022.202.24-263-3.16%
2020/07/1321.8300.001.882277.22%
2020/02/06710.9500.000.927128924.50%
2020/02/05290.9000.000.92292909.99%
2019/04/0800.0030.680.74-3202-1.48%
2019/02/2700.0051.201.14-5129-3.87%
2019/01/2951.3200.001.3451084.62%
2018/10/0200.00151.481.45-15217-6.89%
2018/09/2100.0051.471.48-5217-2.29%
2018/09/1341.6100.001.5642141.87%
2018/09/12101.4800.001.51102124.71%
2018/09/1100.00701.361.45-70208-33.53%
2018/09/0700.0051.701.67-5176-2.84%
2018/08/3000.0091.781.84-9188-4.77%
2018/08/2100.00301.611.61-30183-16.31%
2018/07/3071.9400.001.8571843.80%
2018/07/2731.6700.001.7731661.80%
2018/07/23101.4800.001.48101297.74%
2018/04/03151.9600.001.951510913.69%
2018/02/2700.0052.232.24-5125-3.98%
2018/02/2652.2800.002.2851263.96%
2017/11/2900.000.32.422.41-0.3279-0.09%
2017/10/1200.00252.982.98-25312-8.01%
2017/10/11253.0700.002.99253098.09%
2017/09/2600.00253.043.00-25285-8.77%
2017/09/2500.00302.932.93-30280-10.69%
2017/09/2200.0052.992.90-5273-1.83%
2017/09/2100.00103.043.07-10267-3.74%
2017/09/2000.0092.902.89-9259-3.47%
2017/09/0892.8412.832.8382563.12%
2017/09/0600.00102.582.61-10236-4.23%
2017/08/29102.1200.002.12101885.29%
2017/08/2562.0700.002.0661853.24%
2017/08/2342.0500.002.0541822.19%
2017/07/2072.2072.132.1301660.00%
2017/07/1300.0062.112.15-6165-3.63%
2017/07/1200.0052.102.17-5174-2.86%
2017/07/1000.00102.102.10-10183-5.45%
華上生醫佈局國際合作 增添營運新動能UDN聯合新聞網-2022/04/14
華上生醫晚期肝癌新藥 將在台啟動二期臨床收案Anue鉅亨-2022/03/04
華上 相關文章